1. Editorial

   • Ewald Wöll

   editorial 04 December 2023 Pages: 213 - 214

   

2. ASCO 2023—partnering with patients: the cornerstone of cancer care and research

   • Gabriel Rinnerthaler

   editorial 04 December 2023 Pages: 215 - 216

3. HER2 in focus—gastric cancer

   • Aysegül Ilhan-Mutlu

   editorial 04 December 2023 Pages: 217 - 217

4. Prostate cancer special—part 1

   • Shahrokh F. Shariat

   editorial 04 December 2023 Pages: 218 - 219

5. Supportive management

   • Christoph Minichsdorfer, PhD

   editorial 04 December 2023 Pages: 220 - 221

6. ASCO 2023: new treatment options in CNS tumors

   • Josef Pichler

   short review 17 August 2023 Pages: 222 - 224

7. Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer

   • Patrick Reimann
   • Thomas Winder

   short review 13 November 2023 Pages: 225 - 229

8. Renal cell carcinoma

   • Jasmin Spiegelberg

   short review Open access 07 November 2023 Pages: 230 - 233

9. ASCO update—hepatocellular carcinoma and cholangiocellular carcinoma

   • Angela Djanani

   short review Open access 27 October 2023 Pages: 234 - 236

10. Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma

    • Aysegül Ilhan-Mutlu
    • Ewald Wöll

    short review Open access 19 October 2023 Pages: 237 - 241

11. Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction

    • Sophie Roider-Schur
    • Sybille Machat
    • Leopold Öhler

    case report 27 October 2023 Pages: 242 - 245

    

12. Comment to Smith MR, Hussain M, Saad F et al. (2022, N Engl J Med) Darolutamide and survival in metastatic, hormone-sensitive prostate cancer

    • Isabel Heidegger
    • Andreas Pircher

    comment 04 July 2022 Pages: 246 - 246

13. Focal therapy in intermediate- and high-risk prostate cancer

    • Nicolai A. Huebner
    • Stephan Korn
    • Shahrokh F. Shariat

    short review Open access 10 November 2023 Pages: 247 - 250

14. Imaging and therapy targeting PSMA receptors for enhanced vision and precise treatment

    • Sazan Rasul
    • Stephan Korn

    short review Open access 19 October 2023 Pages: 251 - 254

15. Challenges in prevention, early detection, and management of febrile neutropenia in adult patients with solid tumors

    • Petar Popov

    short review Open access 29 August 2023 Pages: 255 - 258

    

16. Erythropoiesis-stimulating agents—benefits and harms in the treatment of anemia in cancer patients

    • Ronald Heregger
    • Richard Greil

    short review Open access 28 August 2023 Pages: 259 - 262

17. Management of malignant hypercalcemia in cancer patients—a short review

    • Clemens Petrasch
    • Petra Marics
    • Thomas Spanberger

    short review 03 November 2023 Pages: 263 - 267

18. WNT3 and LEF1 as markers for diagnosis and survival prediction in chronic lymphocytic leukemia patients

    • Manal Atef
    • Layla M. Saleh
    • Sameh Shamaa

    original report 13 October 2020 Pages: 268 - 274